163 related articles for article (PubMed ID: 37530216)
1. Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
Ungericht M; Groaz V; Messner M; Schuetz T; Brunelli L; Zaruba MM; Lener D; Stocker E; Bauer A; Kroiss AS; Mayr A; Röcken C; Poelzl G
Amyloid; 2024 Mar; 31(1):22-31. PubMed ID: 37530216
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
[TBL] [Abstract][Full Text] [Related]
4. Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
Wollenweber T; Kretschmer-Chott E; Wurm R; Rasul S; Kulterer O; Rettl R; Duca F; Bonderman D; Sühs KW; Hacker M; Traub-Weidinger T
J Nucl Cardiol; 2023 Feb; 30(1):357-367. PubMed ID: 35817943
[TBL] [Abstract][Full Text] [Related]
5. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
6. Quantitative
Caobelli F; Braun M; Haaf P; Wild D; Zellweger MJ
J Nucl Cardiol; 2020 Oct; 27(5):1456-1463. PubMed ID: 31538322
[TBL] [Abstract][Full Text] [Related]
7. DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.
Scully PR; Morris E; Patel KP; Treibel TA; Burniston M; Klotz E; Newton JD; Sabharwal N; Kelion A; Manisty C; Kennon S; Ozkor M; Mullen M; Hartman N; Elliott PM; Pugliese F; Hawkins PN; Moon JC; Menezes LJ
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1353-1363. PubMed ID: 32498921
[TBL] [Abstract][Full Text] [Related]
8. Cardiac transthyretin amyloidosis
Löfbacka V; Axelsson J; Pilebro B; Suhr OB; Lindqvist P; Sundström T
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1822-1832. PubMed ID: 33367948
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications.
Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY
Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903
[TBL] [Abstract][Full Text] [Related]
10. Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
Rettl R; Wollenweber T; Duca F; Binder C; Cherouny B; Dachs TM; Camuz Ligios L; Schrutka L; Dalos D; Beitzke D; Loewe C; Badr Eslam R; Kastner J; Hacker M; Bonderman D
Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1019-1030. PubMed ID: 36881774
[TBL] [Abstract][Full Text] [Related]
11. An optimized imaging protocol for [
Schatka I; Bingel A; Schau F; Bluemel S; Messroghli DR; Frumkin D; Knebel F; Diekmann SM; Elsanhoury A; Tschöpe C; Hahn K; Amthauer H; Rogasch JMM; Wetz C
J Nucl Cardiol; 2021 Dec; 28(6):2483-2496. PubMed ID: 34331215
[TBL] [Abstract][Full Text] [Related]
12. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of
Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
[TBL] [Abstract][Full Text] [Related]
14. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
15. Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.
Avalon JC; Fuqua J; Deskins S; Miller T; Conte J; Martin D; Marano G; Yanamala N; Mills J; Bianco C; Patel B; Seetharam K; Raylman R; Sengupta PP; Hamirani YS
J Nucl Cardiol; 2023 Feb; 30(1):127-139. PubMed ID: 35655113
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.
Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Cunha N; Rodrigues T; Santos L; Conceição I; Agostinho J; Pinto FJ
Amyloid; 2024 Mar; 31(1):32-41. PubMed ID: 37493395
[TBL] [Abstract][Full Text] [Related]
17. Quantitative
Kessler L; Fragoso Costa P; Kersting D; Jentzen W; Weber M; Lüdike P; Carpinteiro A; Oubari S; Hagenacker T; Thimm A; Rassaf T; Herrmann K; Papathanasiou M; Rischpler C
J Nucl Cardiol; 2023 Feb; 30(1):101-111. PubMed ID: 35562639
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of [
Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
[TBL] [Abstract][Full Text] [Related]
19. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
20. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
